Clinical Outcome Data of Children Treated with Cannabis-Based Medicinal Products for Treatment Resistant Epilepsy—Analysis from the UK Medical Cannabis Registry

Background  There is a paucity of high-quality evidence of the efficacy and safety of cannabis-based medicinal products in treatment of treatment-resistant epilepsy (TRE) in children. Methods  A case series of children (<18 years old) with TRE from the UK Medical Cannabis Registry was analyzed. P...

Descripción completa

Detalles Bibliográficos
Autores principales: Erridge, Simon, Holvey, Carl, Coomber, Ross, Hoare, Jonathan, Khan, Shaheen, Platt, Michael W., Rucker, James J., Weatherall, Mark W., Beri, Sushil, Sodergren, Mikael H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166640/
https://www.ncbi.nlm.nih.gov/pubmed/36539215
http://dx.doi.org/10.1055/a-2002-2119

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166640/
https://www.ncbi.nlm.nih.gov/pubmed/36539215
http://dx.doi.org/10.1055/a-2002-2119

Ejemplares similares